Principles and applications of nanomaterial-based hyperthermia in cancer therapy.
Jin Kook KangJae Chang KimYuseon ShinSang Myung HanWoong Roeck WonJaewon HerJune Yong ParkKyung Taek OhPublished in: Archives of pharmacal research (2020)
Over the past few decades, hyperthermia therapy (HTT) has become one of the most promising strategies to treat cancer. HTT has been applied with nanotechnology to overcome drawbacks such as non-selectivity and invasiveness and to maximize therapeutic efficacy. The high temperature of HTT induces protein denaturation that leads to apoptosis or necrosis. It can also enhance the effects of other cancer therapies because heat-damaged tissues reduce radioresistance and help accumulate anticancer drugs. Gold nanoparticles and superparamagnetic iron oxide with different energy sources are commonly used as hyperthermia agents. New types of nanoparticles such as those whose surface is coated with several polymers and those modified with targeting moieties have been studied as novel HTT agents. In this review, we introduce principles and applications of nanotechnology-based HTT using gold nanoparticles and superparamagnetic iron oxide.
Keyphrases
- iron oxide
- gold nanoparticles
- cancer therapy
- papillary thyroid
- high temperature
- squamous cell
- drug delivery
- oxidative stress
- reduced graphene oxide
- cell death
- squamous cell carcinoma
- stem cells
- lymph node metastasis
- young adults
- drinking water
- bone marrow
- dna damage
- small molecule
- iron oxide nanoparticles
- cell therapy
- chemotherapy induced